BioXcel Therapeutics, Inc. (BTAI)
Data as of , from SEC Form 4 filings.
See up to 3 months of BTAI. The 7-day demo opens the 1M and 3M ranges and puts BTAI on your watchlist.
Start 7-day demoLatest BTAI insider trades
- Frank Yocca - OfficerOpen-market sale$7K
- Javier Rodriguez - OfficerOpen-market sale$7K
Richard I. Steinhart
About BioXcel Therapeutics, Inc. (BTAI)
The SEC lists BioXcel Therapeutics, Inc. under CIK 0001720893, in pharmaceutical preparations. We track it alongside the rest of the Health Care sector.
BTAI Form 4 activity by transaction type, last 90 days
| Form 4 transaction type | Transactions | Shares | Total value |
|---|---|---|---|
| Grant or award | 1 | 17,000 |
Dollar totals cover purchases and sales only (codes P and S). Grants, option exercises, gifts and tax withholding are counted in shares, because none of them is a trade at a market price.
BTAI insider transactions (Form 4)
5347 Form 4 filings on record, the earliest from Oct 3, 2024, newest first. Filing history page 2 of 2.
| Date | Insider | Transaction | Security | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Frank Yocca - Officer | Grant or award | Common Stock | 4,375 | - | - | |
| Javier Rodriguez - Officer | Grant or award | Common Stock | 4,375 | - | - | |
| Javier Rodriguez - Officer | Option exercise | Common Stock | 625 | - | - | |
| Javier Rodriguez - Officer | Option exercise | Restricted Stock Units | 625 | $0.00 | - | |
| Richard I. Steinhart - Officer | Grant or award | Common Stock | 4,375 | - | - | |
| Richard I. Steinhart - Officer | Option exercise | Common Stock | 625 | - | - | |
| Richard I. Steinhart - Officer | Option exercise | Restricted Stock Units | 625 | $0.00 | - | |
| Richard I. Steinhart - Officer | Option exercise | Common Stock | 33 | - | - | |
| Richard I. Steinhart - Officer | Option exercise | Common Stock | 35 | - | - | |
| Richard I. Steinhart - Officer | Option exercise | Restricted Stock Units | 33 | $0.00 | - | |
| Richard I. Steinhart - Officer | Option exercise | Restricted Stock Units | 35 | $0.00 | - | |
| Richard I. Steinhart - Officer | Grant or award | Restricted Stock Units | 625 | $0.00 | - | |
| Richard I. Steinhart - Officer | Grant or award | Stock Option (right to buy) | 1,875 | $0.00 | - | |
| Vimal Mehta - Officer | Option exercise | Common Stock | 2,610 | - | - | |
| Vimal Mehta - Officer | Option exercise | Common Stock | 3,500 | - | - | |
| Vimal Mehta - Officer | Open-market sale | Common Stock | 983 | $0.36 | $358 | |
| Vimal Mehta - Officer | Open-market sale | Common Stock | 2,134 | $0.36 | $773 | |
| Vimal Mehta - Officer | Option exercise | Restricted Stock Units | 2,610 | $0.00 | - | |
| Vimal Mehta - Officer | Option exercise | Restricted Stock Units | 3,500 | $0.00 | - | |
| Javier Rodriguez - Officer | Option exercise | Common Stock | 521 | - | - | |
| Javier Rodriguez - Officer | Option exercise | Common Stock | 562 | - | - | |
| Javier Rodriguez - Officer | Open-market sale | Common Stock | 210 | $0.36 | $75 | |
| Javier Rodriguez - Officer | Open-market sale | Common Stock | 220 | $0.36 | $78 | |
| Javier Rodriguez - Officer | Option exercise | Restricted Stock Units | 521 | $0.00 | - | |
| Javier Rodriguez - Officer | Option exercise | Restricted Stock Units | 562 | $0.00 | - | |
| Frank Yocca - Officer | Option exercise | Common Stock | 521 | - | - | |
| Frank Yocca - Officer | Option exercise | Common Stock | 562 | - | - | |
| Frank Yocca - Officer | Open-market sale | Common Stock | 205 | $0.36 | $73 | |
| Frank Yocca - Officer | Open-market sale | Common Stock | 225 | $0.35 | $79 | |
| Frank Yocca - Officer | Option exercise | Restricted Stock Units | 521 | $0.00 | - | |
| Frank Yocca - Officer | Option exercise | Restricted Stock Units | 562 | $0.00 | - | |
| Vincent O'Neill - Officer | Option exercise | Common Stock | 521 | - | - | |
| Vincent O'Neill - Officer | Open-market sale | Common Stock | 165 | $0.35 | $58 | |
| Vincent O'Neill - Officer | Option exercise | Restricted Stock Units | 521 | $0.00 | - | |
| Richard I. Steinhart - Officer | Option exercise | Common Stock | 521 | - | - | |
| Richard I. Steinhart - Officer | Option exercise | Common Stock | 562 | - | - | |
| Richard I. Steinhart - Officer | Open-market sale | Common Stock | 205 | $0.36 | $74 | |
| Richard I. Steinhart - Officer | Open-market sale | Common Stock | 372 | $0.36 | $133 | |
| Richard I. Steinhart - Officer | Option exercise | Restricted Stock Units | 521 | $0.00 | - | |
| Richard I. Steinhart - Officer | Option exercise | Restricted Stock Units | 562 | $0.00 | - | |
| David J. Mack - Director | Option exercise | Common Stock | 27,089 | - | - | |
| David J. Mack - Director | Grant or award | Restricted Stock Units | 297,988 | $0.00 | - | |
| David J. Mack - Director | Grant or award | Restricted Stock Units | 325,077 | $0.00 | - | |
| Matthew T. Wiley - Officer | Grant or award | Common Stock | 21,250 | - | - | |
| Matthew T. Wiley - Officer | Open-market sale | Common Stock | 6,272 | $0.55 | $3K | |
| Javier Rodriguez - Officer | Grant or award | Common Stock | 21,250 | - | - | |
| Javier Rodriguez - Officer | Open-market sale | Common Stock | 6,863 | $0.55 | $4K | |
| Frank Yocca - Officer | Grant or award | Common Stock | 21,250 | - | - | |
| Frank Yocca - Officer | Open-market sale | Common Stock | 7,175 | $0.55 | $4K | |
| Vincent O'Neill - Officer | Grant or award | Common Stock | 21,250 | - | - | |
| Vincent O'Neill - Officer | Open-market sale | Common Stock | 5,556 | $0.55 | $3K | |
| Richard I. Steinhart - Officer | Grant or award | Common Stock | 21,250 | - | - | |
| Richard I. Steinhart - Officer | Open-market sale | Common Stock | 7,175 | $0.55 | $4K |
Recent BTAI Form 144 notices of proposed sale
3An insider files Form 144 before selling restricted or control stock. It announces a planned sale. If the sale goes ahead, it shows up later on a Form 4.
| Filed | Filer | Relationship | Shares | Market value | Notice |
|---|---|---|---|---|---|
| - | - | - | - | View on EDGAR | |
| - | - | - | - |
BTAI insider trading FAQ
What is the latest insider trade for BTAI?
BioXcel Therapeutics, Inc. (BTAI) had 1 insider filing in the last 90 days, with the most recent on 2026-08-14. The full record for BTAI runs to 47 Form 4 filings, the earliest from 2024-10-03. InsiderAlpha adds new Form 4, Form 144 and 8-K filings as they arrive from SEC EDGAR.
How many insiders are buying BTAI stock?
No insider purchases of BTAI were filed in the last 90 days.
How many insiders are selling BTAI stock?
No insider sales of BTAI were filed in the last 90 days. 18 sales are on record for this company.
Where can I see BTAI SEC filings (Form 4, 10-K, 10-Q, 8-K)?
This page collects BTAI Form 4 insider transactions, Form 144 sale notices and 8-K filings in one place. Annual 10-K and quarterly 10-Q reports live on the company's SEC EDGAR page.
More Health Care companies with insider activity
Recent insider filings
10The EDGAR links open each original Form 4, so you can check any number on this page against the filing it came from.
- - Susan E. Atkins view on EDGAR
- - Javier Rodriguez view on EDGAR
- - Richard I. Steinhart view on EDGAR
- - Frank Yocca view on EDGAR
- - Vimal Mehta view on EDGAR
- - Frank Yocca view on EDGAR
- - Javier Rodriguez view on EDGAR
- - Richard I. Steinhart view on EDGAR
- - Vimal Mehta view on EDGAR
Related companies with recent insider activity
Learn more
- What the Form 4 transaction codes mean
- Grants, option exercises, gifts and tax withholding are not trades on the market. The codes say which is which.
- Form 144 vs Form 4
- A Form 144 announces a planned sale; the Form 4 reports it after it happens.
- Insider activity in Health Care
- Where BTAI's peers are being bought and sold.
- Every recent Form 4
- The market-wide feed, updated as filings arrive from SEC EDGAR.
Follow BTAI with a 7-day demo
- BTAI on your watchlist
- Every BTAI Form 4 filing on record
- Up to 3 months of BTAI price history
- The daily trading plan of ranked insider buys, on a delay, with the plan archive
